AI Science Tracker

Affiliation not reported

4 discoveries from 2025 to 2026

Discoveries

GPT-6 Pro proves an optimal anticoncentration bound for polynomial Littlewood–Offord inequalities

Source check: Source checked. Not independent scientific confirmation.

Finding: The source presents a proof discovered autonomously by GPT-6 Pro establishing an O_d(r^{-1/2}) zero-probability bound for degree-d multilinear polynomials with r disjoint degree-d monomials, improving the prior bound by removing a polylogarithmic factor and resolving the Nguyen–Vu conjecture. The key argument also proves a total-influence estimate for bounded-degree rational functions, resolving a recent conjecture of Kothari, Kovacs-Deak, Wang and Yang; these are one connected paper-level result, not separate entries.

Technology: OpenAI GPT-6 Pro

Family GPT-6: profile · models page

Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
The author states that GPT-6 Pro autonomously discovered the proof and that the author claims no credit for the proof ideas; the author subsequently verified, digested and rewrote the argument.
Test and result
The source presents a proof discovered autonomously by GPT-6 Pro establishing an O_d(r^{-1/2}) zero-probability bound for degree-d multilinear polynomials with r disjoint degree-d monomials, improving the prior bound by removing a polylogarithmic factor and resolving the Nguyen–Vu conjecture.
Limitation / still unknown
This is an arXiv preprint. The author reports personally verifying and rewriting the proof; this review has not independently formalized it. Bound and related rational-function influence result are counted once because the paper derives them as a connected argument.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://arxiv.org/abs/2610.08708

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

GPT-5.6 constructs a counterexample to Talagrand’s operator cotype problem

Source check: Source checked. Not independent scientific confirmation.

Finding: The paper gives a negative answer, already for q=2, to Talagrand’s question whether an operator’s Rademacher cotype is universally bounded by its Gaussian cotype and its (q,1)-summing norm. For every sufficiently large power-of-two dimension it constructs a Banach space and operator violating such a universal bound. The same construction also yields a negative answer to Kwapień’s decomposition problem.

Technology: ChatGPT GPT-5.6

Family GPT-5: profile · models page

Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
The author states that the counterexample was discovered during discussions with GPT-5.6. The paper presents an explicit Walsh–Hadamard-based construction and proof; the author independently verified the arguments.
Test and result
The paper gives a negative answer, already for q=2, to Talagrand’s question whether an operator’s Rademacher cotype is universally bounded by its Gaussian cotype and its (q,1)-summing norm.
Limitation / still unknown
This is a single-author arXiv preprint, not a peer-reviewed publication. GPT-5.6 is credited with discovering the counterexample during discussions; the author says they independently verified all arguments. No Lean or other proof-assistant formalization is reported. The mathematical scope is the stated q=2 counterexample and its stated corollary, not a complete characterization of operator cotype.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://arxiv.org/abs/2609.19731

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Deep-learning allosteric-site prediction identifies celestolide as Botrytis CYP51 inhibitor

Source check: Needs source check. Not independent scientific confirmation.

Finding: Celestolide inhibited CYP51 (IC50 133.28 ug/mL), showed antifungal activity and extended strawberry shelf life by more than a week in a gray-mold model. IC50 is weak in absolute terms; abstract only; field efficacy untested.

Technology: Neural relational inference and CorrSite2.0 (Gaussian network deep learning model)

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Models identified the allosteric site used to select celestolide.
Test and result
Celestolide inhibited CYP51 (IC50 133.28 ug/mL), showed antifungal activity and extended strawberry shelf life by more than a week in a gray-mold model.
Limitation / still unknown
IC50 is weak in absolute terms; abstract only; field efficacy untested.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:%2210.1021/acs.jafc.5c05257%22&resultType=core&format=json

Needs source check · editorial details

The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 17 Nov 2026. Review scope: Abstract and metadata via Europe PMC; full text not read.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Deep-learning de novo GLP-1RAs show half-life about 3x semaglutide in mice

Source check: Needs source check. Not independent scientific confirmation.

Finding: 10,000 designed GLP-1RAs; 60 passed criteria; 62% in vitro success; two had half-lives about three times semaglutide and the best candidate outperformed semaglutide in diabetic and obesity mouse models. Preprint; mouse data only; head-to-head claims not independently checked; affiliations not read.

Technology: Deep-learning protein design plus functional screening

Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Deep-learning design generated peptide candidates before wet-lab screening.
Test and result
10,000 designed GLP-1RAs; 60 passed criteria; 62% in vitro success; two had half-lives about three times semaglutide and the best candidate outperformed semaglutide in diabetic and obesity mouse models.
Limitation / still unknown
Preprint; mouse data only; head-to-head claims not independently checked; affiliations not read.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:%2210.1101/2025.03.26.645438%22&resultType=core&format=json

Needs source check · editorial details

The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 17 Nov 2026. Review scope: Abstract and metadata via Europe PMC; full text not read.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.